KWALITY PHARMACEUTICALS
Back to Income Statement
|
KWALITY PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹24 Cr | ₹19 Cr | ₹120 Cr | ₹15 Cr | ₹8.32 Cr |
What is the latest Consolidated Net Profit of KWALITY PHARMACEUTICALS ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹24 Cr |
Mar2023 | ₹19 Cr |
Mar2022 | ₹120 Cr |
Mar2021 | ₹15 Cr |
Mar2020 | ₹8.32 Cr |
How is Consolidated Net Profit of KWALITY PHARMACEUTICALS Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹24 Cr | 22.83 | |
Mar2023 | ₹19 Cr | -83.85 | |
Mar2022 | ₹120 Cr | 692.23 | |
Mar2021 | ₹15 Cr | 82.11 | |
Mar2020 | ₹8.32 Cr | - |
Compare Consolidated Net Profit of peers of KWALITY PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KWALITY PHARMACEUTICALS | ₹705.0 Cr | -4% | -3.4% | 40.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,012.0 Cr | 4.6% | -0.9% | 5.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,188.0 Cr | 0.5% | -5.5% | 57.2% | Stock Analytics | |
CIPLA | ₹118,041.0 Cr | 0.2% | 0.6% | -3.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,512.0 Cr | -0.4% | -1.5% | 14.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,445.1 Cr | -2.2% | -8.6% | -13.4% | Stock Analytics |
KWALITY PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KWALITY PHARMACEUTICALS | -4% |
-3.4% |
40.5% |
SENSEX | -0.7% |
-4.5% |
-0.4% |
You may also like the below Video Courses